Advertisement
Screener

CANDEL THERAPEUTICS, INC. (CADL) ROA

CANDEL THERAPEUTICS, INC. (CADL) ROA

  • 2026-06-30: ROA -42.53%.
  • 2026-03-31: ROA -26.95%.
  • 2025-12-31: ROA -30.50%.
  • 2025-09-30: ROA -24.32%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-42.53%
2026-03-31-26.95%
2025-12-31-30.50%
2025-09-30-24.32%
2025-06-30-20.89%
2025-03-31-41.27%
2024-12-31-51.63%
2024-09-30-242.59%
2024-06-30-188.74%
2024-03-31-119.69%
2023-12-31-92.08%
2023-09-30-63.78%
2023-06-30-54.81%
2023-03-31-39.73%
2022-12-31-24.19%
2022-09-30-14.25%
2022-06-30-21.00%
2022-03-31-32.02%
2021-12-31-40.50%
2021-09-30-50.23%
2021-06-30-112.51%

Annual ROA

DateROA
2025-12-31-30.50%
2024-12-31-51.63%
2023-12-31-92.08%
2022-12-31-24.19%
2021-12-31-40.50%
2020-12-31-46.18%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61